Описание деятельности
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
Правление & Наблюдательный совет
| Исполнительный директор |
| Richard A. Gonzalez |
| Правление |
| Scott T. Reents, Carrie Strom, Dr. Azita Saleki-Gerhardt, Jeffrey R. Stewart, Perry C. Siatis, Rae L. Livingston, Robert A. Michael, Timothy J. Richmond, Kevin Buckbee, Nicholas Donoghoe, Tracie Haas, Thomas Hudson, Greg Miley, Elaine K. Sorg |
| Наблюдательный совет |
| Richard A. Gonzalez, Brett J. Hart, Edward J. Rapp, Frederick H. Waddell, Glenn F. Tilton, Melody B. Meyer, Rebecca B. Roberts, Robert J. Alpern, Roxanne S. Austin, Thomas Freyman, William H.L. Burnside |
Данные компании
| Имя: |
AbbVie Inc. |
| Адрес: |
1 North Waukegan Road,North Chicago, Illinois 60064-6400, USA |
| Телефон: |
+1-847-932-7900 |
| Факс: |
- |
| E-mail: |
-
|
| Интернет: |
www.abbvie.com/ |
| Индустрия: |
Healthcare |
| Сектор: |
Pharmaceutical Industry |
| Подсектор: |
Pharmaceuticals |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
96.70% |
| Дата IPO: |
02.01.2013 |
Связи с инвесторами
| Имя: |
Liz Shea |
| IR телефон: |
+1-847-935-2211 |
| IR-факс: |
- |
| IR e-mail: |
liz.shea@abbvie.com
|
